| INTRODUC TI ON

Human respiratory syncytial virus (RSV), recently renamed as
Human orthopneumovirus belonging to the Pneumoviridae family Orthopneumovirus genus, 1 is one of the most important viral pathogens which causes lower respiratory tract illness (LRTI) including bronchiolitis and pneumonia, especially in infants and young children. 2, 3 Respiratory syncytial virus is divided into two subgroups, A and B, based on antigenic and sequence variations. The predominant subgroup and proportion of each subgroup vary between epidemics. 4 A recent global estimate showed that the incidence of RSV-associated acute lower respiratory infection was 33.1 million, with 3.2 million hospital admissions and 59 600 in-hospital deaths in children younger than 5 years old in 2015. 5 Despite the burden of this disease, there are no commercially available vaccines and the monoclonal antibody is only a specific measure taken to prevent severe disease in high-risk infants. 6, 7 The incidence rate (IR) of RSV-associated lower respiratory illness (RSV-LRTI) is higher in the first 6 months of life compared with older age groups, and the illness is generally more severe in young infants. 5, 8 For these reasons, it is believed that natural maternal immunity is not enough to prevent severe RSV-LRTI in early infancy. Different strategies for vaccination, including maternal vaccination and infant vaccination, have been proposed to prevent severe infection. 9, 10 However, effective implementation of these strategies depends on understanding the epidemiological patterns of severe infections, including age-specific incidences.
Respiratory syncytial virus infections are associated with various levels of respiratory illnesses, from cold-like mild illness to very severe and even life-threatening LRTI. To evaluate the disease burden and effectiveness of vaccines or other interventions, it is necessary to define the severity of RSV infection. 11 To identify severe LRTI with hypoxaemia, percutaneous arterial oxygen saturation (SpO 2 ) measurement by a pulse oximeter has been shown to be effective. Studies have reported that the recognition of hypoxaemia using a pulse oximeter improved the management of children with LRTI. 12, 13 It was also shown that one of the most important indicators for severe RSV-LRTI was an SpO 2 level of less than 90%. 14 Recently, the World Health Organization (WHO) expert group proposed that the measurement of SpO 2 should be included in the severity definition for RSV-LRTI. 11 Several prospective cohort studies have been conducted in low-and middle-income countries to define age-specific IRs. [15] [16] [17] [18] [19] [20] [21] [22] However, to date, few studies have reported the IR of RSV-LRTI using standard definitions of severity. Hence, in this study, we analysed the data from a community-based prospective cohort study of children younger than five years old to understand in detail the age-specific incidence of RSV-LRTI, using the definitions proposed by the WHO expert group. 11 We examined possible risk factors for developing RSV-LRTI and severe RSV-LRTI and compared clinical manifestations between severe and non-severe cases using data from a community-based prospective cohort study in the Philippines. Further, we evaluated the level of concordance between the severity of the LRTI definitions and the classification based on the integrated management of childhood illness (IMCI). 23 
| MATERIAL S AND ME THODS
| Study design
In the previously described prospective cohort study, 24 ,25 a cohort of 4012 children younger than 5 years old was followed in two munici- 
| Definition of RSV-associated RTI
An RTI was defined as a respiratory episode with cough and/or difficult breathing. A new episode was identified if the onset of the new RTI episode was at least 7 days from the previous episode. An episode of RSV-associated RTI (RSV-RTI) was defined based on positive laboratory results for RSV. If there were two RSV-positive samples within a month, the episode with the latter positive sample was considered as prolonged shedding, except if the RSV subgroups or the partial G gene sequences were different from each other.
| Classification of RTI severity
We categorised RTIs into LRTI, severe LRTI and very severe LRTI based on the severity definitions proposed by the WHO expert
cohort study, lower respiratory tract illness, pulse oximetry, respiratory syncytial virus group (Supporting Information Table S1 ). 11, 26 Briefly, LRTI was defined as RTI with fast breathing (≥50 breaths/min in children aged 2-11 months, ≥40 breaths/min in children aged 12-59 months) or SpO 2 < 95%; severe LRTI as LRTI with chest indrawing or SpO 2 < 93%
and very severe LRTI as LRTI with inability to feed, sleeping most of the time, difficult to wake or SpO 2 < 90%. When RTI occurred in children aged 0-1 month, the severity could not be defined based on the WHO definitions mentioned above. 11, 26 Therefore, for this age group, we categorised RTI with ≥60 breaths/min or SpO 2 < 95%
as LRTI and RTI with chest indrawing or SpO 2 < 93% as severe LRTI. We also classified RSV-associated respiratory disease using Integrated Management of Child Illness (IMCI), both with and without the revision proposed in 2014. 26 In this revision, children with pneumonia having chest indrawing without danger signs were classified as "pneumonia" (non-severe disease). Hospitalisation of the children with severe respiratory disease was indicated by local treating physician.
| Viral detection and defining RSV subgroups
Nasopharyngeal swabs were collected from RTI for RSV testing as described previously, 27 including real-time polymerase chain reaction (PCR) to screen for RSV, 28, 29 conventional PCR for subgrouping and sequencing of the second variable region of the G gene (RSV-A:
342 bp and RSV-B: 330 bp). 30, 31 Testing for RSV and other viruses, including rhinovirus, enterovirus, human metapneumovirus, human adenovirus, parainfluenza virus and influenza virus, was conducted using primers described in Supporting Information Table S2 . Details of the procedure were described elsewhere. 24 We did not exclude RSV-RTI with other viruses from the analysis. Figure S1 ). Among total severe RSV-LRTI (n = 101), 26 had SpO 2 measured after starting oxygen treatment and at least 24% (24/101) had SpO 2 < 90%, but only three were hospitalised. The proportion of RSV-associated hospitalisation was 7.1% (28/395). Of these (n = 28), SpO 2 data were available for 12 children and 25% (3/12) of those had SpO 2 < 90%. There were 13 undefined RSV-RTI episodes in children aged 0-1 month, of which eight (61.5%)
| Statistical methods
were hospitalised, all with chest indrawing, and three (23.1%) had SpO 2 < 93% (Supporting Information Table S3 ). None of the 408 RSV-RTI episodes was fatal.
| Comparison between classification systems of severity
Among the 395 cases of children aged 2 months or older, using the RSV-LRTI severity definition, the median age of children with RSV-RTI was inversely associated with severity (Table 1) (Table 1 ).
| Age-specific IRs of RSV-LRTI
The overall IRs of total RSV-LRTI and total severe RSV-LRTI were 62.1 and 22.1 per 1000 child-years in children aged 2-59 months, 25 [11, 42] 19 [11, 30] 16 [10, 23] 12 [6, 17] 18 [10, 27] 15 [9, 22] 19 [10, 31] Age in months, n (%) 2-5
14 (13) 30 (16) 10 (14) 6 (21) 46 (16) 16 (16) 60 (15) 6-11
19 (17) 17 (9) 11 (15) 8 (28) 36 (13) 19 (19) 55 (14) 12-23
21 (19) 70 (38) 36 (50) 12 (41) 118 (42) 48 (48) 139 (35) 24-35
21 (19) 32 (17) 4 (6) 3 (10) 39 (14) 7 (7) 60 (15) 36-59
36 (32) 34 (19) 11 (15) 0 (0) 45 (16) 11 (11) 81 (20) Sex, n (%) Male 51 (46) 90 (49) 41 (57) 20 (69) 151 (53) 61 (60) 202 (51) Female 60 (54) 93 (51) 31 (43) 9 (31) 133 (47) 40 (40) 193 (49) Place of living (municipality), n (%) Caibiran 67 (60) 132 (72) 48 (67) 16 (55) 196 (69) 64 (63) 263 (66) Kawayan 44 (40) 51 (28) 24 (33) 13 (45) 88 (31) 37 (37) 134 (34) Health facility, n (%) Outpatient 110 (99) 183 (100) 55 (76) 19 (66) 257 (90) 74 (73) 367 (93) Hospitalisation 1 (1) 0 (0) 17 (24) 10 (34) 27 (10) 27 (27) 28 (7) IMCI classification, n (%) Cough and cold 109 (98) 7 (4) 4 (6) 3 (10) 14 (5) 7 (7) 123 (31) Pneumonia 0 (0)
173 (94) 15 (21) 9 (31) 197 (69) 24 (24) 197 (69) Severe pneumonia or severe disease 2 (2) 3 (2) 53 (74) 17 (59) 73 (26) 70 (69) 75 (26) Revised IMCI classification, n (%) Cough and cold 109 (98) 7 (4) 4 (6) 3 (10) 14 (5) 7 (7) 123 (31) Pneumonia 0 (0)
173 (94) 68 (94) 15 (52) 256 (90) 83 (82) 256 (65) Severe pneumonia or severe disease 2 (2) 3 (2) 0 (0) 11 (38) 14 (5) 11 (11) 16 (4) RSV subgroup RSV-A 38 (34) 42 (23) 27 (38) 8 (28) 77 (27) 35 (35) 115 (29) RSV-B
70 (63) 131 (72) 43 (60) 17 (59) 191 (67) 60 (59) 261 (66)
10 (5) 2 (3) 4 (14) 16 (6) 6 (6) 19 (5) Co-detected other viruses, n (%) Human adenovirus
independently without using fast breathing. Incidence rates of RSV-RTI episodes with chest indrawing and SpO 2 < 93% were still high in those aged 12-20 months, and particularly IR in 12-14 months was higher than those in 6-8 months for both chest indrawing and SpO 2 < 93%. (Supporting Information Figure S3 ).
The proportion of the total severe RSV-LRTI episodes among total RSV-LRTI was 42.7% (35/82) in the first year of life (2-11 months) with the highest proportion in 9-11 months (Figure 2 ). The proportion did not decline in the second year of life (40.7%, 48/118, P = 0.777) and decreased significantly only in the third year of life (17.9%, 7/39, P = 0.010).
| Risk factor analysis for developing total RSV-LRTI and total severe RSV-LRTI
In the univariate analysis, younger age group, place of living and educational level of caregiver were significantly associated with developing both total RSV-LRTI and total severe RSV-LRTI (Table 2) .
Birth order and having other children aged <6 years in the same household were significantly associated with developing total severe RSV-LRTI. After the adjustment, younger age group was still significantly associated with developing both total RSV-LRTI (range of aHR:
1.7-8.5) and total severe RSV-LRTI (range of aHR: 7.5-11.3) compared with the age group of 36-59 months (Table 2) . Living in the munici- with severe cases after adjusting for age group, gender and place of living (Table 3) . Grunting, decreasing breath sound and alar flaring had high specificity of more than 97%. The positive predictive value for severe cases was high for alar flaring (85.7%), whereas the nega- 13 (7) 8 (11) 3 (10) 24 (8) 11 (11) 30 ( TA B L E 1 (Continued) significantly associated with SpO 2 < 93% (P < 0.05), without high levels of agreement (kappa statistic: 0.1-0.3) ( Table 3 ).
| D ISCUSS I ON
Using data from a prospective cohort study of rural communities in the Philippines, we examined the incidence rates and severity of RSV-LRTI in detail. We estimated the overall IR of total RSV-LRTI to be 62.1 per 1000 child-years in children aged 2-59 months. These rates are comparable to recent global estimates for IRs in low-to upper-middle-income countries, which are in the range of per 1000 child-years in children aged 0-59 months (from limited data with different methodologies). 5 Other community-based cohort studies conducted in low-and middle-income countries have reported higher IRs for total RSV-LRTI of up to 71-94 per 1000 child-years in Nigeria, Kenya and Indonesia. 15, 18, 20 Such differences may be due to the fact that these studies conducted active case findings of children with acute respiratory symptoms, whereas we analysed children who visited health facilities, potentially underestimating IRs.
We found that age-specific IRs were significantly higher in children younger than 2 years old than in the older age group, and the same pattern was observed for total severe LRTI. Among those, the IRs of total RSV-LRTI and total severe RSV-LRTI were especially high in children aged 3-5 months. Peak IRs found in previous similar studies were 3-5 months in Nigeria, 0-5 months in Kenya and 6-8 months in Indonesia. 15, 18, 20 In the Indonesian study, the IR was lower in children aged 3-5 months than in those aged 6-8 months, which may have been related to different factors such as the level of maternal antibodies 35, 36 or breastfeeding practice, 37 since young infants were likely to develop RSV-associated bronchiolitis and F I G U R E 2 Age-specific incidence rates of RSV-LRTI and distributions of followed up child-years in children aged less than 5 y in Biliran cohort study from April 2014 to March 2016. LRTI, lower respiratory tract illness; RSV, respiratory syncytial virus. The proportion of severe episodes was calculated as proportion of the total severe RSV-LRTI episodes among total RSV-LRTI by every 1 y of age. Incidence rates were calculated for 2 mo of age and every 3 mo of ages from 3 to 59 mo of ages. Child-years were calculated for every 3 mo of ages. The childyears during RSV epidemic period is shown as dark grey in background, and light grey shows child-years out of RSV epidemic period. The epidemic periods were defined as pneumonia. 38 Interestingly, we found that IRs dropped in children aged 6-8 months and 9-11 months, then increased again in children aged 12-14, 15-17 and 18-20 months (Figure 2) , in a pattern similar to previous studies. 15, 18, 20 In hospital-based studies, a majority of RSV-associated severe infections are seen in infants aged <1 year, especially in young infants aged <6 months. 19, 39 However, our study and other prospective cohort studies have identified similar bimodal peaks in IRs of total RSV-LRTI, that is, young infants aged <6 months and children aged 12-23 months. We suspected that the increased IRs in children aged 12-20 months might be due to the change in the criteria for fast breathing at 12 months old. However, the agespecific IRs of severe RSV-LRTI defined by only chest indrawing or SpO 2 < 93% showed similar patterns, suggesting a true increase in incidence in the second years of life. Age-specific IRs might also be affected by the timing of RSV epidemics since observed child-year for each age group did not cover whole epidemic periods. Therefore, we compared the proportion of epidemic period in total observed child-years for each age group. We found not much difference in the proportions of epidemic periods between age groups. The agespecific pattern of IRs for RSV-LRTI has important implications for future intervention strategies including vaccination. While current vaccination strategies focus primarily on protecting young infants, if the IRs of RSV-LRTI (especially the more severe cases) are also high in children 12-23 months, vaccination strategies may need to consider including a booster dose before 12 months.
In our study, 13 undefined RSV-RTI episodes were identified in children aged <2 months due to unavailability of severity definitions. 11, 26 Eight were hospitalised, and all of these had chest indrawing and three of them had SpO 2 < 93%. Therefore, more than half of RSV-RTI in children aged <2 months were considered to be severe.
Incidence rates for those with chest drawing and SpO 2 < 93% were highest in this age group, indicating the significant impact of RSV-RTI in this age group. To reveal true burden and risk factors for this age group, further studies, particularly large-scale birth cohort studies, should be conducted.
We found that younger age of children (range of aHRs for total RSV-LRTI and total severe RSV-LRTI: 1.7-8.5 and 7.5-11.3, respectively), living in Caibiran (aHRs for total RSV-LRTI: 2.4, 95% CI:
1.9-3.1 and for total severe RSV-LRTI: 1.9, 95% CI: 1.3-2.8) and lower educational level of caregivers (range of aHRs for total RSV-LRTI: 1.5-1.7) were significant risk factors for the development of total RSV-LRTI and total severe RSV-LRTI (Table 2) . Caibiran had a larger epidemic of RSV, and particularly RSV-B, in 2015. aHR, adjusted hazard ratio; HH, household; HR, hazard ratio; IR, incidence rate; LRTI, lower respiratory tract illness; RSV, respiratory syncytial virus.
Total RSV-LRTI consists of RSV-LRTI, severe RSV-LRTI and very severe RSV-LRTI. Total severe RSV-LRTI consists of severe RSV-LRTI and very severe RSV-LRTI. Caregiver is the person that takes care of the child, knows best about the child and makes decisions for the best interest of the child. Solid fuel contains wood, charcoal, paper, etc a Adjusted for age group, sex, place of living, gestational age, birthweight, educational level of caregiver and number of other children <6 y in household.
b
Adjusted for age group, sex, place of living, gestational age, birth order, educational level of caregiver and father and number of other children <6 y in household.
c
Hazard ratio for breastfeeding status was adjusted for age group, sex, place of living and educational level of caregiver and calculated using subset data for 2-6 y old.
* P < 0. and non-exclusive breastfeeding (OR: 2.2), identified in a metaanalysis, 42 were not significant risk factors in the present study.
Prematurity and low birthweight were significantly associated with acute lower respiratory infection in case-control studies conducted in the hospital settings with a large number of children with severe RSV-LRTI in high-income countries. 42 In our study, which mainly included cases in primary care, we did not reach the statistical significance probably due to the insufficient number of children with low birthweight, prematurity and severe RSV-LRTI.
In other low-and middle-income countries, only unpublished data of one case-control study and one cohort study for prematurity and one cohort study for low birthweight were conducted and none of these studies showed prematurity or low birthweight as a significant risk factor for severe RSV-LRTI. 42 Children whose gestational age or birthweight was not reported by their mothers (categorised as "unknown") were less likely to develop RSV-LRTI compared with the reference group. There may be a recall bias that mothers who could not recall were more likely to have had children with normal weight and gestational age.
We included a relatively large number of children in our cohort study, but the number was still too small to assess all possible risk factors. Most other studies of risk factors have been conducted as casecontrol studies, which are more suitable for evaluating risk factors that occur with low frequency, such as prematurity and low birthweight. 42 In another prospective cohort study in Bohol, the Philippines, being male and having siblings were identified as significant risk factors, 43 although there were some differences in the study designs. The Bohol study used RSV-associated hospitalisation as an outcome and had twice as many participants as our study. On the other hand, a birth cohort study in Kilifi, Kenya, with fewer participants than ours, 44 having 1-2 siblings less than 6 years old living in the same household, was a statistically significant risk factor for developing total RSV-LRTI. Thus, further studies are necessary to comprehensively evaluate various risk factors for developing severe RSV infections.
As a previous study showed, 45 clinical manifestations, such as wheezing, rale, alar flaring and chest indrawing, were significantly associated with SpO 2 < 93% in our study. However, these clinical manifestations had low level of agreement with SpO 2 . Predicting hypoxaemia by clinical manifestation seemed difficult because no sole clinical sign had high sensitivity and specificity as described elsewhere. 45, 46 The combination of the clinical manifestations in
Usen et al's study in Gambia had 70% of sensitivity and 79% of specificity. 45 Moreover, 32% of severe and 62% of very severe cases were only defined by SpO 2 level without meeting other clinical criteria of the WHO RSV-LRTI case definition. Therefore, it should be emphasised that the diagnostic value of SpO 2 measurement increased as the level of severity increased. Some studies have shown that hypoxaemia is more prevalent in children with RSV-LRTI compared with LRTI with other aetiology. 47, 48 In our study, 19% (19/101) of the total severe RSV-LRTI had SpO 2 < 90%.
However, only 16% (3/19) of those were actually hospitalised.
Taken together, testing for hypoxaemia is crucial for evaluation of children with RSV-associated RTI to identify severe cases. Home care for children with LRI should be considered with SpO 2 measurement. However, setting a cut-off point for application of the oxygen therapy and providing the necessary equipment are important to support health workers' decision.
One limitation of our study was that we only included episodes observed in health facilities. Since health-seeking behaviour can vary among age groups, 49 we may have underestimated the IRs, particularly in older children who are less likely to visit health facilities than infants. Also, our study only included two sites from the same small island with two epidemics over two years, and thus, our results, including IRs, may not reflect the true burden. In addition, the study was not conducted as a birth cohort and most newborn infants
were not recruited for the study immediately after birth. Therefore, observed child-years in this age group were particularly small in infants aged less than 3 months.
| CON CLUS ION
Although young infants had the highest risk of developing severe and very severe RSV-LRTI, there were also significant impacts on the second year of life. Future interventions, including vaccination, should consider children up to two years old as a population vulnerable to severe RSV-LRTI. Integrated child care approaches should include the use of a pulse oximeter to evaluate the severity of LRTI, and adequate oxygen treatment should be given to severe LRTI with hypoxaemia.
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